A carregar...
Improving the operational efficiency of Phase 2 and 3 trials
The period toward the end of patients’ participation in late stage blinded clinical trials is highly resource intensive for the sponsor. Consider first a Phase 3 trial. If the trial is a success, the sponsor has to implement the next steps, which might be filing for approval of the drug with the US...
Na minha lista:
| Publicado no: | Trials |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4955134/ https://ncbi.nlm.nih.gov/pubmed/27439520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1465-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|